Analysis of the Effectiveness of Globe Incision Mammaplasty in the Treatment of Early Breast Cancer

  • Zhu Wu Jingzhou First People's Hospital
  • Zhuo Wang Jingzhou First People's Hospital
  • Qingqing Ye Jingzhou First People's Hospital
  • Rong Fan Jingzhou First People's Hospital
DOI: https://doi.org/10.18686/aem.v12i2.383
Keywords: Breast Cancer, Racket Incision Mammaplasty, Efficacy Observation

Abstract

Objective: To observe the efficacy of different methods in the treatment of early stage breast cancer disease. Methods: 84 patients admitted from 2020.12 to 2022.8 were divided into groups I and II, 42 patients each, who received treatment after conventional breast-conserving and racket-shaped incision mammoplasty, respectively, and compared the surgical treatment of patients between groups. Results: The rates of cosmetic excellence and complications in group II were 95.2% and 7.1% respectively, compared with 73.8% and 35.7% in group I. The differences reached a significant level (X² 5.825,8.556 respectively, P equals 0.016,0.003 both <0.05). Conclusion: The treatment of early breast cancer patients with racket-shaped incisions for mammaplasty is cosmetically effective and safe, and is worth promoting.

References

[1] Tao ZZ, Cao G, Li Y, et al. Analysis of the effect of breast lumpectomy with preserved nipple mastectomy for early breast cancer [J]. Chinese medicine,2020,15(10):1563-1566.

[2] Xu Q, Zheng L, Xu Danying, Liu Yue, Shen Jing. The application of ball-and-shoot incision mammaplasty in breast-conserving surgery for early-stage breast cancer[J]. Chinese general medicine, 2022,20(12):2041-2044.5.

[3] Jin LL. Clinical effects of globe shaped incision mammaplasty in the treatment of breast cancer patients[J]. Clinical Medicine Research and Practice,2020,5(11):71-72.
Published
2023-06-01
Issue
Vol 12, No 2 (2023)
Section
Original Research Article

Copyright (c) 2023 Zhu Wu, Zhuo Wang, Qingqing Ye, Rong Fan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.